Inversely, HIS-SARS2 could activate gene expression by targeting enhancer in human [129], which significantly overlap with the aberrant expressed genes found in bronchoalveolar lavage fluid (BALF) of COVID-19 patients [272]. The gene discussed is SARS2; the disease is COVID-19.